Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 46
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06173531 | Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome | ||
| NCT06159673 | ACP-204 in Adults With Alzheimer's Disease Psychosis | ||
| NCT02762591 | Expanded Access of Pimavanserin for Patients With PD Psychosis | ||
| NCT00628420 | Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics | ||
| NCT00361166 | Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone | ||
| NCT04531982 | Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia | ||
| NCT03994965 | The Sub-Sero Study | ||
| NCT03482882 | Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression | ||
| NCT02970292 | Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1) | ||
| NCT03018340 | Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY) | ||
| NCT05796167 | Pimavanserin for Sleep in Parkinson Disease | ||
| NCT00658567 | A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis | ||
| NCT04776746 | Open-Label Extension Study of Trofinetide for Rett Syndrome | ||
| NCT05240339 | Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD) | ||
| NCT05008835 | Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee | ||
| NCT00490516 | ACP-104 in Acutely Psychotic Subjects With Schizophrenia | ||
| NCT01174004 | A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis | ||
| NCT05357612 | Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases | ||
| NCT04855240 | Evaluate the Efficacy and Safety of ACP-044 for the Treatment of Acute Postoperative Pain Following Bunionectomy | ||
| NCT04988867 | An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome | ||
| NCT05999240 | Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder | ||
| NCT00477672 | A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis | ||
| NCT04181723 | Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™) | ||
| NCT03152292 | The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study | ||
| NCT04809116 | Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept | ||
| NCT04164758 | Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine | ||
| NCT03121586 | Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia | ||
| NCT04279314 | Open-Label Extension Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome | ||
| NCT03623321 | Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease | ||
| NCT05523895 | Pimavanserin for the Treatment of Irritability Associated with Autism Spectrum Disorder | ||
| NCT05895513 | Pimavanserin and Aggression and Social Cognition. | ||
| NCT00550238 | A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis | ||
| NCT04292223 | Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis | ||
| NCT06194799 | ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study | ||
| NCT03575052 | A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease | ||
| NCT00087542 | Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug | ||
| NCT02992132 | Study to Examine the Safety and Efficacy of Pimavanserin for the Treatment of Agitation and Aggression in Alzheimer's Disease (SERENE) | ||
| NCT03968159 | Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment | ||
| NCT05555615 | Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder | ||
| NCT03325556 | Relapse Prevention Study of Pimavanserin in Dementia-related Psychosis | ||
| NCT01518309 | An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients | ||
| NCT04000009 | Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment | ||
| NCT02970305 | Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) | ||
| NCT06420297 | OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome | ||
| NCT03118947 | A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease | ||
| NCT02035553 | A Study of the Safety and Efficacy of Pimavanserin in Patients With Alzheimer's Disease Psychosis |
